This site is archived and is no longer updated. It will be taken offline in mid-July. All the latest AWMSG recommendations, guidance and information is available on our new website at: https://awmsg.nhs.wales/.
awmsg logo



amlodipine besilate (Istin®)


Reference No. 2005

Publication date:
01/08/2013


Appraisal information

amlodipine besilate (Istin®) 5 mg orodispersible tablet
amlodipine besilate (Istin®) 10 mg orodispersible tablet


Company: Pfizer Ltd
BNF category: Cardiovascular system
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 29/07/2013

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, amlodipine besilate (Istin®) orodispersible tablets cannot be endorsed for use within NHS Wales for the treatment of hypertension, chronic stable angina pectoris or vasospastic (Prinzmetal’s) angina.
Statement of Advice (SOA)
Download